Malignant transformation of endometriosis into endometrioid ovarian carcinoma with a contralateral borderline seromucinous tumour: A rare case report.
- 1Department of Obstetrics and Gynaecology, Rao Hospital, Coimbatore, Tamil Nadu, India.
- 2Rao Hospital, Coimbatore, Tamil Nadu, India.
Abstract
Background
Endometriosis-associated ovarian cancer is uncommon and is most often represented by endometrioid and clear cell carcinomas. Synchronous contralateral borderline ovarian tumours are uncommon and may be missed when gross intraoperative assessment is reassuring.Case
A 43-year-old woman with a confirmed diagnosis of endometriosis for approximately 5 years presented with worsening pelvic pain and menstrual symptoms. A left ovarian endometrioma increased from 6.1 × 6.8 × 5.2 cm in April 2024 to 8.8 × 9 × 9.5 cm in April 2025, with subsequent MRI showing a complex mass with solid components (O-RADS MRI 5). CA-125 was 408.6 U/mL and CA 19-9 was 643.58 U/mL; RMI-I was 1225.8 (U = 3, M = 1, CA-125 = 408.6). Staging laparotomy was performed. Histopathology demonstrated grade 2 endometrioid adenocarcinoma arising in an endometriotic cyst of the left ovary, FIGO stage IC1, while the grossly normal-appearing right ovary contained a borderline seromucinous tumour with endometrioid differentiation. The omentum, peritoneal cytology, and all 31 sampled lymph nodes were negative for malignancy. Immunohistochemistry supported endometrioid carcinoma.Conclusion
This case highlights the importance of interval change and suspicious imaging features in an endometrioma, the limitations of gross intraoperative assessment of the contralateral ovary, and the value of complete histopathological examination in identifying synchronous bilateral ovarian pathology.
Related
- Malignant transformation of deep infiltrating endometriosis at the uterosacral ligament to endometrioid adenocarcinoma: a rare Case Report
- Ovarian endometrioid adenofibroma in a perimenopausal woman with intermittent vaginal bleeding: a case report
- Association of VCP/p97 Expression with Clinicopathological Features and Overall Survival in Endometrioid Endometrial Carcinoma
- Case Report: Primary endometrioid adenocarcinoma of the cervix and secondary cervical involvement by endometrial carcinoma: diagnostic pitfalls and an integrated approach based on two cases
- Complete loss of all mismatch repair protein expression in endometrioid carcinoma: A first case report of null phenotype induced by MLH1 hypermethylation and MSH2 somatic mutation
BibTeX
@article{kiruthika2026malignant,
title = {{Malignant transformation of endometriosis into endometrioid ovarian carcinoma with a contralateral borderline seromucinous tumour: A rare case report.}},
author = {T Kiruthika and Damodar R Rao and Asha Rao and G Padmashri},
journal = {European journal of obstetrics \& gynecology and reproductive biology: X},
year = {2026},
month = oct,
doi = {10.1016/j.eurox.2026.100499},
url = {https://europepmc.org/article/MED/42903660},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Malignant transformation of endometriosis into endometrioid ovarian carcinoma with a contralateral borderline seromucinous tumour: A rare case report.
AU - T Kiruthika
AU - Damodar R Rao
AU - Asha Rao
AU - G Padmashri
PY - 2026
DA - 2026/10/07
JO - European journal of obstetrics & gynecology and reproductive biology: X
DO - 10.1016/j.eurox.2026.100499
UR - https://europepmc.org/article/MED/42903660
AB - Background Endometriosis-associated ovarian cancer is uncommon and is most often represented by endometrioid and clear cell carcinomas. Synchronous contralateral borderline ovarian tumours are uncommon and may be missed when gross intraoperative assessment is reassuring.Case A 43-year-old woman with a confirmed diagnosis of endometriosis for approximately 5 years presented with worsening pelvic pain and menstrual symptoms. A left ovarian endometrioma increased from 6.1 × 6.8 × 5.2 cm in April 2024 to 8.8 × 9 × 9.5 cm in April 2025, with subsequent MRI showing a complex mass with solid components (O-RADS MRI 5). CA-125 was 408.6 U/mL and CA 19-9 was 643.58 U/mL; RMI-I was 1225.8 (U = 3, M = 1, CA-125 = 408.6). Staging laparotomy was performed. Histopathology demonstrated grade 2 endometrioid adenocarcinoma arising in an endometriotic cyst of the left ovary, FIGO stage IC1, while the grossly normal-appearing right ovary contained a borderline seromucinous tumour with endometrioid differentiation. The omentum, peritoneal cytology, and all 31 sampled lymph nodes were negative for malignancy. Immunohistochemistry supported endometrioid carcinoma.Conclusion This case highlights the importance of interval change and suspicious imaging features in an endometrioma, the limitations of gross intraoperative assessment of the contralateral ovary, and the value of complete histopathological examination in identifying synchronous bilateral ovarian pathology.
SN - 2590-1613
ER -